Oral Semaglutide Shown to Lower Risk of Heart Problems in People with Type 2 Diabetes

Oral semaglutide lowers major heart risks in type 2 diabetes, as per The New England Journal of Medicine Novo Nordisk has shared the full results from its SOUL clinical trial, showing that oral semaglutide can lower the risk of major heart problems in people with type 2 diabetes who also have heart disease or kidney […]